Trulieve Cannabis Corp Ordinary Shares (Sub Voting) Analyst Price Targets - Benzinga

Trulieve Cannabis Corp Ordinary Shares (Sub Voting)

TCNNFOTC

Trade with Public

Trade with Public

$11.55

-1.45-11.15%

À la clôture: Jun 8, 5:00 PM EST

$13.40

0.403.08%

Pré-ouverture: Jun 10, 3:00 AM EST

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer

Trulieve Cannabis Corp Ordinary Shares (Sub Voting) Analyst Price Targets

Wall Street analyst price targets and consensus rating for Trulieve Cannabis Corp Ordinary Shares (Sub Voting) (TCNNF).

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$17Upside to Avg. PT+42.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2024	Needham	Matt McGinley	Maintained	Buy	$15
May 10, 2024	Roth MKM	Scott Fortune	PT Raise	Buy	$16→$19
May 10, 2024	Needham	Matt McGinley	PT Raise	Buy	$14→$15
Mar 5, 2024	Seaport Global	Sonny Randhawa	PT Raise	Buy	$12→$16
Mar 1, 2024	Needham	Matt McGinley	PT Raise	Buy	$7→$14
Nov 9, 2023	Needham	Matt McGinley	PT Cut	Buy	$9→$7

More with Benzinga EdgeGet Access

Analyst Ratings News

This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More

Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.

Javier Hasse

This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More

This week's cannabis news: Snoop Dogg expands his cannabis empire, Planet 13 recovers millions, Glass House locks in $50M & top earnings drop.

Javier Hasse

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

Nicolás Jose Rodriguez

85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading

85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2.

Nicolás Jose Rodriguez

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Nicolás Jose Rodriguez

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Nicolás Jose Rodriguez

© 2026 Benzinga | All Rights Reserved